Indication
Mild intermittent asthma
Mild intermittent asthma is a severity classification of asthma, a chronic inflammatory disorder of the lower respiratory system characterized by variable, reversible airflow obstruction and bronchial hyperresponsiveness. Read more about Mild intermittent asthma
8 drugs 5 manufacturers
Drugs that treat it
Common Mild intermittent asthma therapies.
ASTHMANEFRIN REFILL (racepinephrine HCl)
PRIMATENE MIST (epinephrine)
BRONKAID MAX (ephedrine sulfate)
PRIMATENE (ephedrine HCl)
ASTHMA RELIEF (ephedrine sulfate)
BRONKAID MAX (ephedrine sulfate)
PRIMATENE (ephedrine HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMild intermittent asthma is a severity classification of asthma, a chronic inflammatory disorder of the lower respiratory system characterized by variable, reversible airflow obstruction and bronchial hyperresponsiveness.
Affecting pediatric and adult populations alike, it is defined clinically by daytime symptoms occurring two or fewer days per week, nocturnal awakenings occurring two or fewer nights per month, and no interference with normal daily activities between brief flare-ups.
Between episodes, patients typically demonstrate normal baseline pulmonary function with a forced expiratory volume in one second (FEV1) and peak expiratory flow at or above 80% of predicted values, alongside normal spirometric parameters.
- nih.gov
Mild intermittent asthma is a severity classification of asthma, a chronic inflammatory disorder of the lower respiratory system characterized by variable, reversible airflow obstruction and bronchial hyperresponsiveness
- hopkinsmedicine.org
Mild intermittent asthma is a severity classification of asthma, a chronic inflammatory disorder of the lower respiratory system characterized by variable, reversible airflow obstruction and bronchial hyperresponsiveness
- alberta.ca
Affecting pediatric and adult populations alike, it is defined clinically by daytime symptoms occurring two or fewer days per week, nocturnal awakenings occurring two or fewer nights per month, and no interference with normal daily activities between brief flare-ups Between episodes, patients typically demonstrate normal baseline pulmonary function with a forced expiratory volume in one second (FEV₁) and peak expiratory flow at or above 80% of predicted values, alongside normal spirometric param...
- clevelandclinicmeded.com
Affecting pediatric and adult populations alike, it is defined clinically by daytime symptoms occurring two or fewer days per week, nocturnal awakenings occurring two or fewer nights per month, and no interference with normal daily activities between brief flare-ups Between episodes, patients typically demonstrate normal baseline pulmonary function with a forced expiratory volume in one second (FEV₁) and peak expiratory flow at or above 80% of predicted values, alongside normal spirometric param...
Personalize your experience
Follow Mild intermittent asthma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.